$71.030
+1.563 (+2.20%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de TARS por análisis de gráficos similares
Alphio's TARS stock price prediction model matches the current Tarsus Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $73.15 (+3.76%). The 1-week path is $68.23 (-3.22%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Tarsus Pharmaceuticals Inc?
Tarsus Pharmaceuticals Inc is currently not a strong buy due to its low RSI of 26.066 indicating oversold conditions, and a significant insider selling activity increasing by 1503.33%. However, the company has a promising gross margin of 93% and a strong analyst price target range from $100 to $116, suggesting potential upside. The main risk is the negative earnings trend with a forward P/E of 68.027, indicating high valuation relative to earnings.
TARS cerró en $71.03 el Tuesday, tras subir +2.20%
Tarsus Pharmaceuticals Inc (TARS) last closed at $70.5, losing -0.75%. These facts feed the 1-day and 1-week TARS price prediction above.
Factores de la previsión
Los factores de la previsión de Tarsus Pharmaceuticals Inc (TARS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de TARS, ordenadas por similitud.
Análisis de estacionalidad de TARS
Historically the probability of a positive October return for TARS is 75.41%. November offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de TARS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $104.14 | $127.89 | $153.02 | +81.41% |
| Nov 2026 | $70.73 | $114.56 | $154.39 | +62.49% |
| Dec 2026 | $99.13 | $101.61 | $147.86 | +44.13% |
En 2026, se proyecta que Tarsus Pharmaceuticals Inc (TARS) oscile entre $70.73 y $154.39.
Previsión mensual de Tarsus Pharmaceuticals Inc para 2026
En Oct de 2026, se proyecta que Tarsus Pharmaceuticals Inc promedie $127.89, con un mínimo de $104.14 y un máximo de $153.02.
En Nov de 2026, se proyecta que Tarsus Pharmaceuticals Inc promedie $114.56, con un mínimo de $70.73 y un máximo de $154.39.
En Dec de 2026, se proyecta que Tarsus Pharmaceuticals Inc promedie $101.61, con un mínimo de $99.13 y un máximo de $147.86.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.